Table of Contents
- Executive Summary
- Strategic Implications
- Stakeholder Implications
- Introduction
- Overview of DBS
- DBS for Specific Therapeutic Areas
- Parkinson's Disease
- Epilepsy
- Psychiatric Disorders: OCD and Depression
- Headaches
- Companies Developing DBS Systems
- Medtronic
- NeuroPace
- Cyberonics
- Boston Scientific
- Medtrode
- Advanced Neuromodulation Systems
- Impact of DBS on Drug Markets
- Market Implications
- DBS and the PD Market
- DBS and the Epilepsy Market
- DBS and the Psychiatric Markets
- DBS and the Headache Market
- Codevelopment of Pharmacological Agents and DBS
- Outlook for DBS in the Marketplace
- Bibliography
Tables
- 1. Brain Regions Implicated in Epileptic Seizures
- 2. Companies Developing DBS Devices
Figures
- 1. Regions of the Brain Targeted for Deep Brain Stimulation
- 2. Schematic of Deep Brain Stimulation
- 3. Growth of DBS Procedures, by Indication, 2005-2015
|
Related Report
|
View Cart
